Edaravone: Clinical Trials

5 trials of Edaravone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 3, Recruiting 2

Follow Edaravone: new trials by email Literature Review of Edaravone trials Research Report on Edaravone

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Study of Ultra-early Mobile Stroke Unit Neuroprotection Combined With Revascularization for Acute Ischemic Stroke (EXCELLENT)
Intravenous thrombolysis + edaravone, IV thrombolysis + placebo (control group) - Ischemic Stroke
Phase 4RecruitingRuijun Ji3002024-08-012025-08-12
Edaravone Dexborneol for Blood-Brain Barrier Repair in Acute Anterior Circulation Stroke
Edaravone, Edaravone Dexborneol - Acute Ischemic Stroke
Phase 4RecruitingShandong Provincial Hospital4322021-10-012026-11-12
Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke
Edaravone, Sodium Ozagrel - Cerebral Infarction
Phase 4CompletedShionogi4012004-08-312026-10-21
Edaravone and Argatroban Stroke Therapy Study for Acute Ischemic Stroke
Edaravone - Stroke
Phase 4CompletedCombination Therapy for Acute Ischemic Stroke Study Group8142004-08-012008-05-14
Pilot Study of Edaravone to Treat Acute Myocardial Infarction
edaravone - Myocardial Infarction, Reperfusion Injury
Phase 4CompletedKumamoto University1042001-04-012014-09-15

Conditions studied

Ischemic Stroke (3)  ·  Cerebral Infarction (1)  ·  Myocardial Infarction (1)  ·  Reperfusion Injury (1)  ·  ST Elevation Myocardial Infarction (1)  ·  Stroke (1)

Sponsors

Combination Therapy for Acute Ischemic Stroke Study Group (1)  ·  Kumamoto University (1)  ·  Ruijun Ji (1)  ·  Shandong Provincial Hospital (1)  ·  Shionogi (1)

Countries

China (2)  ·  Japan (2)

Top investigators

Hisao Ogawa, MD, PhD (1)  ·  Takenori Yamaguchi, MD, PhD (1)

Results publications

PMID 19321945, PMID 22633681